ArticleAmerican journal of cancer research2024

PCMT1 confirmed as a pan-cancer immune biomarker and a contributor to breast cancer metastasis.

Yiqi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.